Volume 27, Number 1—January 2021
Dispatch
Detection of Norovirus Variant GII.4 Hong Kong in Asia and Europe, 2017−2019
Table 1
Collection date | Strain designation | City and country of origin | Settings | Patient age/sex | Sequence availability | GenBank accession no. |
---|---|---|---|---|---|---|
2017 May | RS17–1713 | Pangasinan, Philippines | Inpatient* | 11 mo/M | Complete capsid | MT774555 |
2017 Nov | Zandvoort/0471 | Zandvoort, the Netherlands | Sporadic† | 23 mo/F | Full genome | MT735394 |
2018 Mar | CUHK-NS-1772 | Hong Kong, China | Inpatient‡ | 15 y/M | Partial polymerase/capsid | MT577843 |
2019 Mar | WT_NORO_0887 | Manchester, UK | Nursing home§ | 90 y/F | Full genome | MT742777 |
2019 Aug | CUHK-NS-2200 | Hong Kong, China | Inpatient¶ | 42 y/F | Full genome | MN400355# |
*Eight (12.1%) of 66 genotyped norovirus samples tested positive for GII.4 Hong Kong in 2017 in Philippines. †One (0.2%) of 482 genotyped norovirus samples tested positive for GII.4 Hong Kong in the 2017–18 season in the Netherlands. ‡One (0.3%) of 307 genotyped norovirus samples tested positive for GII.4 Hong Kong in 2018 in Hong Kong. §One (1.0%) of 105 genotyped norovirus samples tested positive for GII.4 Hong Kong in the 2018–19 season in the United Kingdom. ¶One (0.3%) of 368 genotyped norovirus samples tested positive for GII.4 Hong Kong in 2019 in Hong Kong. #Prototype sequence of the GII.4 Hong Kong variant.
1Current affiliation: Research Office, Food and Health Bureau, Hong Kong, China.
2Members who contributed data are listed at the end of this article.